The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir ; volume:42 ; number:8 ; day:27 ; month:5 ; year:2023 ; pages:951-958 ; date:8.2023
European journal of clinical microbiology & infectious diseases ; 42, Heft 8 (27.5.2023), 951-958, 8.2023
- Urheber
-
Krifors, Anders
Karlsson, Linda
Ekman, Martin
Lorant, Camilla
Skorup, Paul
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10096-023-04627-4
- URN
-
urn:nbn:de:101:1-2023101809275520247040
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Krifors, Anders
- Karlsson, Linda
- Ekman, Martin
- Lorant, Camilla
- Skorup, Paul
- SpringerLink (Online service)
Ähnliche Objekte (12)
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Kinetics of dengue viremia and its association with disease severity: an ambispective study
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Mechanisms Contributing to Control of Viremia
Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
Remdesivir: A Review in COVID-19
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Kinetics of dengue viremia and its association with disease severity: an ambispective study
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Mechanisms Contributing to Control of Viremia
Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
Remdesivir: A Review in COVID-19
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
Utility of SARS-CoV-2 Subgenomic RNA in Kidney Transplant Recipients Receiving Remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
Kinetics of dengue viremia and its association with disease severity: an ambispective study
Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
HIV-1 persistent viremia is frequently followed by episodes of low-level viremia
Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor
Mechanisms Contributing to Control of Viremia
Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients
Remdesivir: A Review in COVID-19